Table 3

Clinical and echocardiographic characteristics associated with more severe tricuspid regurgitation in patients with RHD

At baselineUnadjustedMultivariable adjustment for age, female sex, atrial fibrillation, SPAP, LVEF and RA areaMultivariable adjustment for age, female sex, atrial fibrillation, SPAP, LVEF, RA area and RV dysfunction*
OR (95% CI)P valueOR (95% CI)P valueOR (95% CI)P value
Age, years1.062 (1.041 to 1.084)<0.0011.049 (1.017 to 1.081)0.0021.061 (1.029 to 1.094)<0.001
Female sex1.069 (0.556 to 2.055)0.8411.706 (0.701 to 4.151)0.2391.986 (0.795 to 4.964)0.142
Atrial fibrillation4.755 (2.925 to 7.728)<0.0011.650 (0.717 to 3.797)0.2391.042 (0.425 to 2.552)0.929
SPAP (mm Hg)1.029 (1.017 to 1.042)<0.0011.051 (1.030 to 1.071)<0.0011.041 (1.021 to 1.061)<0.001
LVEF (%)0.943 (0.918 to 0.969)<0.0010.995 (0.995 to 1.0376)0.7961.008 (0.965 to 1.053)0.728
RA area (cm2)1.238 (1.173 to 1.308)<0.0011.196 (1.117 to 1.281)<0.0011.188 (1.115 to 1.265)<0.001
RV dysfunction*7.793 (4.683 to 12.967)<0.0012.927 (1.401 to 6.115)0.004
  • Model without RV dysfunction: C-statistic of 0.878 (95% CI 0.836 to 0.920).

  • Model with RV dysfunction: C-statistic of 0.888 (95% CI 0.844 to 0.932).

  • *RV function was assessed using a combination of parameters and categorised in normal or impaired function.

  • LVEF, left ventricular ejection fraction; RA, right atrium; RHD, rheumatic heart disease; RV, right ventricular; SPAP, systolic pulmonary artery pressure.